Daxcel reviews the progress and key initiatives of Accelerate 2030, specifically highlighting growth investments and business strengthening measures, while introducing efforts toward achieving future targets.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4202","jir_company_name":"Daxcel","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-05-25","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/4202-20260525-01.pdf","jir_short_summary":"Daxcel reviews the progress and key initiatives of Accelerate 2030, specifically highlighting growth investments and business strengthening measures, while introducing efforts toward achieving future targets.","jir_summary":"### Review of Business Strategy and Key Initiatives\nDaxcel reviews the progress of Accelerate 2030 and continues to focus on strengthening its business and expanding investments as key initiatives to drive growth. The company aims to grow in the fields of medical devices, health foods, and environmentally sustainable materials, emphasizing market expansion domestically and internationally. It promotes new investments and research & development to enhance competitiveness, while also optimizing existing operations and improving profitability.\n\n### Future Goals and Key Initiatives\nTo accelerate growth beyond 2026, Daxcel is pursuing diversification and global expansion, with a particular focus on growth in the China and India markets. The company plans to strengthen investments and R&D efforts to expand sales and profits, aiming for sales of 675.0 billion yen and an operating income margin of over 15% by 2030. It actively addresses social issues such as environmental sustainability and next-generation development, pursuing sustainable growth.","jir_financial_highlights":"Net Sales: Unknown (Unknown)\nOperating Income Margin: Unknown (Unknown)\nEBITDA: Unknown (Unknown)","jir_category":"","jir_hashtags":"#Daxcel, #MidTermStrategy, #JapaneseStocks","jir_key_figures":"Net Sales: Unknown\nOperating Income Margin: Unknown\nSales Target: 675.0 billion yen (2030)","jir_meta_title":"\u3010Daxcel\u3011Progress of Accelerate 2030 and Future Growth Strategy\uff5cMay 2026","jir_meta_description":"Daxcel reviews the progress and key initiatives of the mid-term strategy Accelerate 2030, detailing plans to accelerate growth investments and global expansion. Aims for sales of 6,750 billion yen by 2030.","jir_og_title":"\u3010Daxcel\u3011Progress of Accelerate 2030 and Future Growth Strategy\uff5cMay 2026","jir_og_description":"Daxcel explains the progress of its mid-term strategy and upcoming key initiatives. The plan focuses on global expansion and increased investments to reach sales of 6,750 billion yen by 2030.","jir_og_image_url":"\/assets\/og\/company-disclosure_update.jpg","jir_chart_data_collection":"[]","ir_related_company":8036,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"disclosure_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-54241","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n